youtube_live
Q3 2026 earnings • released • EPS beat +7,77% • Revenue beat +2,95%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
USD 150,04
arrow_downward
-2,21%(-3,39) 1D
6 Nov., 12:05:05 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
USD 141,83
High
USD 151,34
Low
USD 136,42
Mkt. cap
20,13 mjd
Avg. vol.
1,86 m
Volume
2,88 m
52-wk high
USD 191,05
52-wk low
USD 74,55
EPS
-USD 3,50
Beta
1,67
Shares outstanding
134,20 m
No. of employees
2 k
Open
USD 141,83
High
USD 151,34
Low
USD 136,42
Mkt. cap
20,13 mjd
Avg. vol.
1,86 m
Volume
2,88 m
52-wk high
USD 191,05
52-wk low
USD 74,55
EPS
-USD 3,50
Beta
1,67
Shares outstanding
134,20 m
No. of employees
2 k
News stories
From web sources and news partners
Investing.com
·
5 uur gelede
Guardant Health stock reiterated at Buy by BTIG after Q3 beat
Yahoo Finance
·
5 uur gelede
Guardant Health Shares Fall 5.5% as Higher Cash Burn Forecast Overshadows Strong Q3 Revenue Growth
Zacks
·
16 uur gelede
Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates
Traders Union
·
16 uur gelede
Guardant Health announces Q3 results and raises guidance after stock ends session down 9.1%
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2,5 k
Founded2012
HeadquartersPalo Alto, Kalifornië, Verenigde State van Amerika
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com